Sabby Capital
14
43M
13
1.17
0.07
12
- Stages of investment
- Areas of investment
Summary
The leading representative office of defined Corporate Investor is situated in the Upper Saddle River. The venture was found in North America in United States.
The usual cause for the fund is to invest in rounds with 7-8 partakers. Despite the Sabby Capital, startups are often financed by Third Rock Ventures, New Enterprise Associates, Roche Venture Fund. The meaningful sponsors for the fund in investment in the same round are RA Capital Management, Perceptive Advisors, Rock Springs Capital. In the next rounds fund is usually obtained by Perceptive Advisors, Pontifax, Commercial Street Capital.
Among the most popular fund investment industries, there are Biopharma, Therapeutics. Among the various public portfolio startups of the fund, we may underline Epic Sciences, Arno Therapeutics, Stem Cell Therapeutics The fund has no exact preference in some founders of portfolio startups. In case when startup counts 3 or 5+ of the founder, the chance for it to get the investment is meager. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
Deals in the range of 50 - 100 millions dollars are the general things for fund. The high activity for fund was in 2014. The fund is constantly included in less than 2 investment rounds annually. The higher amount of exits for fund were in 2015. This Sabby Capital works on 63 percentage points more the average amount of lead investments comparing to the other organizations.
We also calculated 1 valuable employee in our database.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 14
- Lead investments
- 0
- Exits
- 12
- Rounds per year
- 1.17
- Follow on index
- 0.07
- Investments by industry
- Biotechnology (13)
- Therapeutics (7)
- Health Care (6)
- Biopharma (5)
- Medical (4) Show 9 more
- Investments by region
-
- United States (10)
- Canada (2)
- Australia (1)
- Peak activity year
- 2015
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 13
- Avg. valuation at time of investment
- 43M
- Group Appearance index
- 1.00
- Avg. company exit year
- 6
- Avg. multiplicator
- 0.69
- Strategy success index
- 0.80
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Dermira | 19 Aug 2014 | Biotechnology, Pharmaceutical, Biopharma | Late Stage Venture | 51M | United States, California |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.